MedPath

Sarcopenia and Intervention Physical Therapy

Not Applicable
Not yet recruiting
Conditions
Sarcopenia
Registration Number
NCT07013604
Lead Sponsor
Pharos University in Alexandria
Brief Summary

To evaluate and compare the effectiveness of neuromuscular electrical stimulation (NMES) and low-load resistance training with blood flow restriction (BFR) in improving muscle mass, strength, functional performance, and quality of life in elderly individuals diagnosed with sarcopenia

Detailed Description

Sarcopenia, the age-related decline in muscle mass, strength, and function, significantly affects the health and independence of elderly individuals. It increases the risk of frailty, falls, and disability. Neuromuscular electrical stimulation (NMES) and low-load resistance training with blood flow restriction (BFR) are promising rehabilitation strategies for older adults with limited physical capacity. This study aims to compare the effectiveness of NMES and BFR in managing sarcopenia and improving physical and functional outcomes in the elderly

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Older age (≥ 60-75 years)

Low muscle strength (e.g., low handgrip strength)

Low muscle mass (e.g., ASM/height² below cutoff)

Exclusion Criteria
  • heart disese
  • kidny disese
  • autoimune disese
  • cognetive disorder
  • sever form of sarcopenia

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Change in Muscle Mass2 month

Assessed using Bioelectrical Impedance Analysis (BIA) to measure skeletal muscle mass.

Evaluation is done pre- and post-intervention to detect changes in the Skeletal Muscle Index (SMI), based on EWGSOP2 criteria

Secondary Outcome Measures
NameTimeMethod
Muscle Strength Handheld dynamometer (e.g., MicroFET)2 month

Isometric knee extension strength

Measurement: Pre- and post-intervention, using the highest or average value from 2-3 trials.

Timed Up and Go (TUG) Test2 month

Assesses eight domains of health-related quality of life, scored from 0 to 100. Administered before and after the intervention period

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.